Gyre Therapeutics Balance Sheet
Gyre Therapeutics's total assets for Q4 2025 were $166.13M, an increase of 4.23% from the previous quarter. GYRE total liabilities were $23.85M for the fiscal quarter, a 8.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.